Non-Current Assets
Total Assets
Abbott Total Assets increased by 24439.8% to $110.43B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 35.6%, from $81.45B to $110.43B. Over 5 years (FY 2020 to FY 2025), Total Assets shows a downward trend with a -63.8% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
StatementBalance Sheet Statement
SectionNon-Current Assets
CategoryMarket Position
SignalHigher is better
VolatilityStable
First reportedQ3 2015
Last reportedQ4 2025
How to read this metric
Growth in total assets typically mirrors the overall expansion of the business, provided it is accompanied by corresponding revenue growth.
Detailed definition
The aggregate value of everything the company owns, including both short-term liquid resources and long-term physical an...
Peer comparison
Used to compare the scale of operations across the industry; larger asset bases generally suggest a more dominant market presence.
Metric ID:
total_assetsHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $73.27B | $73.80B | $75.20B | $74.01B | $74.20B | $72.80B | $74.44B | $73.79B | $73.35B | $72.09B | $73.21B | $72.47B | $73.02B | $74.36B | $81.41B | $81.45B | $84.00B | $84.18B | $450.00M | $110.43B |
| QoQ Change | — | +0.7% | +1.9% | -1.6% | +0.3% | -1.9% | +2.2% | -0.9% | -0.6% | -1.7% | +1.6% | -1.0% | +0.8% | +1.8% | +9.5% | +0.0% | +3.1% | +0.2% | -99.5% | >999% |
| YoY Change | — | — | — | — | +1.3% | -1.3% | -1.0% | -0.3% | -1.1% | -1.0% | -1.6% | -1.8% | -0.5% | +3.1% | +11.2% | +12.4% | +15.0% | +13.2% | -99.4% | +35.6% |
Range$450.00M – $110.43B
CAGR+9.0%
Avg YoY Growth-1.0%
Median YoY Growth-0.4%
Business Segments
| Segment | Q4 '22 | Q4 '23 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Medical Devices | $7.84B | $9.03B | $9.47B | $10.03B | $10.56B | $10.58B | $10.69B | $10.98B |
| Diagnostic Products | $7.99B | $7.77B | $7.68B | $7.84B | $8.18B | $8.20B | $8.27B | $9.63B |
| Nutritional Products | $3.63B | $4.27B | $4.40B | $4.64B | $4.91B | $4.89B | $4.79B | $4.90B |
| Established Pharmaceuticals | $2.88B | $3.12B | $3.09B | $3.45B | $3.73B | $3.73B | $3.54B | $3.67B |
| Total | $74.44B | $73.21B | $81.41B | $81.45B | $84.00B | $84.18B | $450.00M | $110.43B |
Total Assets at Other Companies
Frequently Asked Questions
- What is Abbott's total assets?
- Abbott (ABT) reported total assets of $110.43B in Q1 2026.
- How has Abbott's total assets changed year-over-year?
- Abbott's total assets increased by 35.6% year-over-year, from $81.45B to $110.43B.
- What is the long-term trend for Abbott's total assets?
- Over 5 years (2020 to 2025), Abbott's total assets has grown at a -63.8% compound annual growth rate (CAGR), from $72.55B to $450.00M.
- What does total assets mean?
- The total value of everything the company owns, from cash to buildings.